CRMD, CELC, RANI, and RAPT are pushing aggressively to the upside on Monday. Here's what is driving these four biotech stocks ...

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that at the 2025 European Society for Medical ...

Biotech stocks rebound after years of weakness as M&A, lower rates and easing policy fears draw investors back to the sector.

Leverage RWE strategically to build regulator-ready submissions.

By co-locating sequencing services with cloud analytics, the facility treats data generation and interpretation as a single ...

Claude for Life Sciences is based on Anthropic’s most powerful large language model Claude Sonnet 4.5. It’s designed to ...

After rejecting Replimune’s melanoma drug RP1 this summer, the FDA has accepted the biotech’s resubmission of an approval ...

Investors have grown more cautious about putting their money into the inherently unpredictable drug development industry.

Acadia Pharmaceuticals CEO Catherine Owen Adams breaks down the company’s recent rebrand, its expansion into rare disease marketing and how it’s using AI.

Shares of Chinese drug firm Akeso – likened by some Western media outlets to artificial intelligence start-up DeepSeek – rose ...

Oncolytics Biotech (ONCY) has established a new at-the-market equity financing agreement with BTIG, LLC. As disclosed in a Securities and Exchange Commission ((SEC)) filing on October 17, 2025, the de ...

Australia globally recognised for world-class life sciences but needs more funding from investors to support companies at ...